FDA Approved: UNITUXIN — Supplemental Application (United Therapeutics Corporation)

View source ↗

Summary

FDA granted approval of a supplemental application for Unituxin (dinutuximab) submitted by United Therapeutics Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• UNITUXIN (dinutuximab)

Snippet

SUPPL AP for UNITUXIN (DINUTUXIMAB)